KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Other Accumulated Expenses (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Other Accumulated Expenses for 6 consecutive years, with $2.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Accumulated Expenses rose 244.62% year-over-year to $2.9 million, compared with a TTM value of $2.9 million through Sep 2025, up 244.62%, and an annual FY2024 reading of $3.5 million, down 40.04% over the prior year.
  • Other Accumulated Expenses was $2.9 million for Q3 2025 at Clover Health Investments, down from $3.2 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $5.8 million in Q4 2023 and bottomed at $5000.0 in Q1 2021.
  • Average Other Accumulated Expenses over 5 years is $1.4 million, with a median of $1.2 million recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses skyrocketed 2878.57% in 2023, then tumbled 40.04% in 2024.
  • Year by year, Other Accumulated Expenses stood at $73000.0 in 2021, then surged by 2045.21% to $1.6 million in 2022, then surged by 269.16% to $5.8 million in 2023, then crashed by 40.04% to $3.5 million in 2024, then decreased by 16.88% to $2.9 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for CLOV at $2.9 million in Q3 2025, $3.2 million in Q2 2025, and $3.5 million in Q1 2025.